Trials / Completed
CompletedNCT04064515
CTCs in Cervix Cancer
Identification of Circulating Tumor Cells in Patients With HPV 16 or 18 Associated Cervical Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is a validation study to confirm the ability of Telomescan OBP-401 to identify CTCs in patients with HPV 16 / 18 associated cervical cancer. CTCs identified will be tested for the presence of the HPV 16 / 18 E6 protein, confirming a cervical cancer origin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood Assayed for CTCs | All study participants will have 15 mL of blood drawn for the purpose of the study. |
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2020-04-23
- Completion
- 2020-04-23
- First posted
- 2019-08-22
- Last updated
- 2022-08-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04064515. Inclusion in this directory is not an endorsement.